HIV/AIDS Pathogenesis
Researchers' data advance HIV/AIDS Pathogenesis research
Published in AIDS Weekly, January 16th, 2006
Study 1: Simian immunodeficiency virus integration preference is similar to that of HIV-1.
"Simian immunodeficiency virus (SIV) is a useful model for studying human immunodeficiency virus (HIV) pathogenesis and vaccine efficacy. As with all other retroviruses, integration is a necessary step in the replication cycle of SIV," scientists in the United States report.
"The location of the retrovirus integration site is known to impact on viral gene expression, establishment of viral latency, and other aspects of the replication cycle of a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-01-16)
More Articles from AIDS Weekly
- HIV/AIDS HAART
Genetically distinct HIV-1 quasispecies persist during prolonged HAART - HIV/AIDS HAART
M89I/V protease mutation linked to therapy failure in HIV-1 non-B subtypes - HIV/AIDS Mother-to-Child Transmission
ZDV plus 3TC is the most effective regimen in reducing mother-to-child HIV transmission - HIV/AIDS Pathogenesis
CD4 T cells physically lost with sustained HIV replication - HIV/AIDS Transmission
Vaginal cells are selectively permissive to X4 HIV entry - Adverse Drug Reaction
Antiretroviral toxicity may increase death rate from liver-related disease - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
